In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes.

No abstract is available for this paper.

• Publication year

  1975

• Venue

  JIM - Journal of Immunological Methods

• Publication date

  1975-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0022-1759(75)90090-3PMID 807654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sensitisation of lymphocytes in vitro against human melanoma-associated antigens

  1974cited by this paper
• The induction of tumour immunity in mice using glutaraldehyde-treated tumour cells

  1974cited by this paper
• Fluctuations and distribution of measles virus antigens in chronically infected cells

  1974cited by this paper
• Immune responses in vitro. X. Functions of macrophages.

  1974cited by this paper
• THE EFFECT OF 2-MERCAPTOETHANOL ON MURINE MIXED LYMPHOCYTE CULTURES

  1974cited by this paper
• A modified 51Cr release assay for cytotoxic lymphocytes.

  1974cited by this paper
• In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitized in vitro

  1973cited by this paper
• Cellular immune response against tumor cells. I. In vitro immunization of allogeneic and syngeneic mouse spleen cell suspensions against DBA mastocytoma cells.

  1973cited by this paper
• IN VITRO INDUCTION OF TUMOR-SPECIFIC IMMUNITY

  1973cited by this paper
• The separation of different cell classes from lymphoid organs. IX. A simple and rapid method for removal of damaged cells from lymphoid cell suspensions.

  1973cited by this paper
• T‐Cell‐Mediated Immune Responses Induced in Vitro: A Probe for Allograft and Tumor Immunity

  1973cited by this paper
• Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.

  1973cited by this paper
• Specificity of cellular immune reactivity to virus-induced tumours.

  1972cited by this paper
• Mouse myelomas and lymphomas in culture.

  1970cited by this paper

• Effect of Polyethylene Glycol 6000 on the Generation of Antitumor Cytotoxicity in MOPC-315 Tumor Bearer Spleen Cells Cultured in the Presence or Absence of Inactivated Stimulator Tumor Cells 1

  2006cites this paper
• Effects of propofol vs methohexital on neutrophil function and immune status in critically ill patients

  2006cites this paper
• Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor

  2005cites this paper
• Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extract

  2004cites this paper
• Melphalan-induced enhancement of tumor cell immunostimulatory capacity as a mechanism for the appearance of potent antitumor immunity in the spleen of mice bearing a large metastatic MOPC-315 tumor

  2004cites this paper
• Specificity of the generation and expression of enhanced anti-plasmacytoma immunity by spleen cells from melphalan-treated MOPC-315 tumor bearers

  2004cites this paper
• Modulation of antitumor immunity — Immunobiologic approaches

  2004cites this paper
• Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor

  2004cites this paper
• Effect of low-dose cyclophosphamide therapy on specific and nonspecific T cell-dependent immune responses of spleen cells from mice bearing large MOPC-315 plasmacytomas

  2004cites this paper
• Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma

  1995cites this paper
• Two tumor models of curative adoptive chemoimmunotherapy using tumor-infiltrated spleen cells with potent antitumor cytotoxicity stimulated by antigen-sharing tumors

  1993cites this paper
• Advantages of adoptive chemoimmunotherapy with polyethylene glycol-cultured, antigen-activated, tumor-infiltrated spleen cells for the complete eradication of lethal MOPC-315 plasmacytomas.

  1991cites this paper
• Transplantation resistance to a murine plasmacytoma lacking MHC determinants.

  1990cites this paper
• Lysis of antigenically unrelated tumor cells mediated by Lyt 2+ splenic T-cells from melphalan-cured MOPC-315 tumor bearers.

  1989cites this paper
• Immunoregulation of murine plasmacytoma. I. Generation of anomalous killer cells in vitro by cocultivation with MOPC 104E.

  1989cites this paper
• Interleukin 2 requirement for the in vitro generation of antitumor cytotoxicity by thymocytes from melphalan-cured MOPC-315 tumor bearers.

  1989cites this paper
• Host response to myeloma: I. Induction of cytotoxic and suppressor T cells by in vivo immunization with MOPC 104E plasmacytoma.

  1988cites this paper
• Melphalan-induced appearance of potent antitumor immune reactivity in tumor bearer lymphocytes co-expressing the Lyt 2 and the L3T4 antigens.

  1987cites this paper
• Melphalan-induced enhancement of antitumor immune reactivity in thymocytes of adult BALB/c mice bearing a large MOPC-315 tumor.

  1987cites this paper
• Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.

  1986cites this paper
• Frequency of murine cytotoxic T cell precursors reactive to plasma cell tumour-associated antigens as compared to major histocompatibility antigens.

  1986cites this paper
• Down-regulation of the antitumor immune response.

  1985cites this paper
• Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.

  1985cites this paper
• The murine antitumor immune response and its therapeutic manipulation.

  1984cites this paper
• Tumor-specific immunity induced by somatic hybrids. IV. Relationship between immunogenicity and expression of surface tumor-associated antigens.

  1984cites this paper
• The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy.

  1983cites this paper
• In vitro induction of tumor‐specific immunity by highly purified vsv grown in SV40‐transformed cells and tumor glycolipids incorporated into liposomes

  1983cites this paper
• Tumor immunity to murine plasma‐cell tumors. VIII. Immunosuppression of the generation of cytotoxic T cells by murine plasma‐cell tumor lines

  1983cites this paper
• Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide.

  1983cites this paper
• Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors.

  1982cites this paper
• An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions.

  1982cites this paper
• Studies on natural killer (NK) cells. Heterogeneity of NK cells in beige mutant mice.

  1982cites this paper
• CULTURED NATURAL KILLER CELLS

  1982cites this paper
• Mode of action of polyethylene glycol 6000 in potentiating the in vitro generation of antitumor cytotoxicity by MOPC-315 tumor bearer spleen cells.

  1982cites this paper
• Tumor immunity to murine plasma cell tumors. VII. Expression of H-2 and tumor antigens on Ig synthesis variants of MPC-11.

  1982cites this paper
• Studies on natural killer (NK) cells. III. The effects of in vitro culture on spontaneous cytotoxicity of murine spleen cells.

  1982cites this paper
• T CELL RESPONSES TO ALLOANTIGENS: IV. In Vivo and In Vitro Studies of the Abrogation of Presensitization to Major Histocompatibility Antigens

  1982cites this paper
• Cytotoxic T lymphocyte lines reactive against murine plasmacytoma antigens: Dissociation of cytotoxicity and Lyt‐2 expression

  1982cites this paper
• Tumor-specific immunity induced by somatic hybrids. III. Persistence of adoptively transferred immunity specific for TEPC-15 plasmacytoma in normal BALB/c mice

  1981cites this paper
• Studies on natural killer (NK) cells. II. Serologic evidence for heterogeneity of murine NK cells.

  1981cites this paper
• Culture-generated suppressor cells: evidence for an adherent cell component.

  1981cites this paper
• Spontaneous cytotoxicity.

  1981cites this paper
• Helper factor(s) augment in vitro induction of tumor-specific immunity.

  1981cites this paper
• T CELL RESPONSES TO ALLOANTIGENS II. IN VITRO INDUCTION OF SPECIFIC Ts BY HEAT‐INACTIVATED ALLOGENEIC LYMPHOID CELLS

  1981cites this paper
• T cell responses to alloantigens. III. Prolonged circulation of specific cytotoxic T memory cells following skin allograft rejection in mice.

  1981cites this paper
• Cytotoxic T cells in small intestine epithelial, lamina propria and lung lymphocytes.

  1981cites this paper
• Continuous cytotoxic T cell lines reactive against murine plasmacytoma tumor-associated antigens.

  1981cites this paper
• Heterogeneity of natural killer cells in the mouse.

  1981cites this paper
• Tolerance induction by fusion of fetal thymus lobes in organ culture.

  1980cites this paper
• Differential natural killer cell reactivity against T cell lymphomas by cells from normal or stimulated mice.

  1980cites this paper
• An Fab-related surface component of some normal and neoplastic human and marmoset T cells. Demonstration, functional analysis and partial characterization.

  1980cites this paper
• Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice.

  1980cites this paper
• T cell responses to alloantigens. I. Studies of in vivo and in vitro immunologic memory and suppression by limit dilution analysis.

  1980cites this paper
• Opposite effects of different strains or batches of same strain of BCG on in vitro generation of syngeneic and allogeneic antitumor cytotoxicity.

  1980cites this paper
• Tumor immunity to murine plasma cell tumors. V. Genetic control of the in vitro cytotoxic T-cell response to plasma cell tumor-associated antigens of NZB mice.

  1980cites this paper
• The early appearance of specific cytotoxic T cells in murine gut mucosa.

  1980cites this paper
• Effect of polyethylene glycol 6000 on the generation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells cultured in the presence or absence of inactivated stimulator tumor cells.

  1980cites this paper
• HETEROGENEITY OF NATURAL KILLER CELLS: A SEROLOGICAL STUDY WITH SPECIFIC ANTI-NK ALLOANTISERA

  1980cites this paper
• CHAPTER 3 – Cytotoxic Lymphocytes

  1979cites this paper
• Cell-mediated immune response to syngeneic ultraviolet-induced tumors. II. The properties and antigenic specificities of cytotoxic T lymphocytes generated in vitro following removal from syngeneic tumor-immunized mice.

  1979cites this paper
• Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages.

  1979cites this paper
• Delayed type hypersensitivity to allogeneic cells in mice. I. Requirements for optimal sensitization and definition of the response.

  1979cites this paper
• Ontogeny of culture-generated suppressor cells

  1979cites this paper
• Augmentation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells by depletion of glass-adherent cells prior to in vitro activation.

  1979cites this paper
• INDUCTION OF CONTINUOUS CYTOTOXIC T CELL LINES TO SYNGENEIC PLASMACYTOMA ANTIGENS

  1979cites this paper
• Partial characterization of anti-tumor effector macrophages in the peritoneal cavities of concomitantly immune mice and mice injected with macrophage-stimulating agents.

  1979cites this paper
• Delayed-type hypersensitivity to allogeneic cells in mice. III. Sensitivity to cell-surface antigens coded by the major histocompatibility complex and by other genes

  1979cites this paper
• T lymphocyte-mediated suppression of myeloma function in vitro. I. Suppression by allogeneically activated T lymphocytes.

  1979cites this paper
• Augmentation of antitumor cytotoxicity of MOPC-315 tumor bearer spleen cells by depletion of dinitrophenol-adherent cells prior to in vitro immunization.

  1979cites this paper
• Generation of killer lymphocytes in vitro against human autologous leukemia cells with leukemic blasts and BCG extract

  1979cites this paper
• In vitro cytotoxic response to human myeloma plasma cells by peripheral blood leukocytes from patients with multiple myeloma and benign monoclonal gammopathy.

  1979cites this paper
• In vitro induction and expression of T-cell immunity to tumor-associated antigens.

  1978cites this paper
• Natural cytotoxicity of haemopoietic cell populations against murine lymphoid tumours.

  1978cites this paper
• Cell-mediated immune response to syngeneic UV induced tumors. I. The presence of tumor associated macrophages and their possible role in the in vitro generation of cytotoxic lymphocytes.

  1978cites this paper
• Immune Response in Cancer Patients

  1978cites this paper
• The development of in vitro and in vivo anti-tumor cytotoxicity in noncytotoxic, MOPC-315-tumor-bearer, spleen cells “educated” in vitro with MOPC-315 tumor cells

  1978cites this paper
• In vitro induction of cell-mediated immunity to murine leukemia cells

  1978cites this paper
• MATERNAL ALLOIMMUNISATION IN PREGNANCY: IN VITRO STUDIES OF T CELL‐DEPENDENT IMMUNITY TO PATERNAL ALLOANTIGENS

  1978cites this paper
• Effects of placental tissue on immunological responses.

  1978cites this paper
• Immunogenicity of oncofetal antigens: a review.

  1978cites this paper
• Tumor immunity to murine plasma cell tumours. Influence of responder genotype on the specificity of the immune response to plasmacytomas and T lymphomas.

  1978cites this paper
• Generation of anti-MOPC-315 cytotoxicity in uneducated or in vitro educated spleen cells from normal or MOPC-315 tumor-bearing mice pretreated in vivo with Bacillus Calmette-Guérin.

  1978cites this paper
• An in vivo assessment of in vitro sensitized human lymphocytes using athymic, "nude" mice.

  1978cites this paper
• In vitro induction of tumour-specific immunity V. Detection of common antigenic determinatnts of murine fibrosarcomas.

  1978cites this paper
• Tumor immunity to murine plasma cell tumors. V. Demonstration of a unique tumor antigen that is not associated with the myeloma idiotype

  1978cites this paper
• In vitro induction of tumor specific immunity. VII. Does autosensitization occur with in vitro culture of T lymphocytes?

  1977cites this paper
• Cell mediated cytotoxicity to human melanoma cell lines: Nonspecific active in vitro augmentation

  1977cites this paper
• In vitro primary induction of cytotoxic T cells against virus-infected syngeneic cells.

  1977cites this paper
• Induction of a primary cytotoxic T cell response to lymphocytic choriomeningitis virus-infected cells in vitro. I. Kinetics of response and nature of effector cells.

  1977cites this paper
• Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.

  1977cites this paper
• Inhibition of the growth of lymphoid tumours in syngeneic athymic (nude) mice

  1977cites this paper
• In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens.

  1977cites this paper
• In vitro induction of tumor-specific immunity. IV. Specific adoptive immunotherapy with cytotoxic T cells induced in vitro to plasmacytoma antigens

  1977cites this paper
• In vitro induction of tumor-specific immunity. VI: analysis of specificity of immune response by cellular competitive inhibition: limitations and advantages of the technique.

  1977cites this paper
• Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice.

  1977cites this paper
• The cell-mediated immune response to ectromelia virus infection. I. Kinetics and characteristics of the primary effector T cell response in vivo.

  1976cites this paper
• In vitro induction of cell-mediated immunity to murine leukemia cells. I. Optimization of tissue culture conditions for the generation of cytotoxic lymphocytes.

  1976cites this paper
• In vitro induction of tumor-specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofetal antigens.

  1976cites this paper
• Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression

  1976cites this paper
• DISCUSSION PAPER: IN VITRO AUGMENTATION OF TUMOR IMMUNITY IN A MURINE METHYLCHOLANTHRENE SARCOMA SYSTEM *

  1976cites this paper